Učitavanje...
Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes
The immunological mechanism(s) of action whereby teplizumab preserves C-peptide levels in the progression of patients with recent onset type 1 diabetes (T1D) is still not well understood. In the present study, we evaluated the kinetics of T cell modulation in peripheral blood following two 14-day co...
Spremljeno u:
| Izdano u: | Cell Immunol |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5614459/ https://ncbi.nlm.nih.gov/pubmed/28844471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2017.07.007 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|